Factors That Influence Selectionof Urinary Diversion Among Bladder Cancer Patients in 3 Community-based Integrated Health Care Systems.
Autor: | Kwan ML; Kaiser Permanente Division of Research, Oakland, CA. Electronic address: Marilyn.L.Kwan@kp.org., Leo MC; Kaiser Permanente Center for Health Research, Portland, OR., Danforth KN; Kaiser Permanente Department of Research & Evaluation, Pasadena, CA., Weinmann S; Kaiser Permanente Center for Health Research, Portland, OR., Lee VS; Kaiser Permanente Division of Research, Oakland, CA., Munneke JR; Kaiser Permanente Division of Research, Oakland, CA., Bulkley JE; Kaiser Permanente Center for Health Research, Portland, OR., Rosetti MO; Kaiser Permanente Center for Health Research, Portland, OR., Yi DK; Kaiser Permanente Department of Research & Evaluation, Pasadena, CA., Banegas MP; Kaiser Permanente Center for Health Research, Portland, OR., Wagner MD; Department of Urology, Kaiser Permanente Sunnyside Medical Center, Clackamas, OR., Williams SG; Department of Urology, Kaiser Permanente Riverside Medical Center, Riverside, CA., Aaronson DS; Department of Urology, Kaiser Permanente Oakland Medical Center, Oakland, CA., Grant M; City of Hope Hospital, Duarte, CA., Krouse RS; University of Pennsylvania School of Medicine, University & Woodland Aves., Philadelphia, PA., Gilbert SM; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., McMullen CK; Kaiser Permanente Center for Health Research, Portland, OR. |
---|---|
Jazyk: | angličtina |
Zdroj: | Urology [Urology] 2019 Mar; Vol. 125, pp. 222-229. Date of Electronic Publication: 2018 Nov 22. |
DOI: | 10.1016/j.urology.2018.09.037 |
Abstrakt: | Objective: To assess the relative contributions of patient and surgeon factors for predicting selection of ileal conduit (IC), neobladder (NB), or continent pouch (CP) urinary diversions (UD) for patients diagnosed with muscle-invasive/high-risk nonmuscle invasive bladder cancer. This information is needed to enhance research comparing cancer survivors' outcomes across different surgical treatment options. Methods: Bladder cancer patients' age ≥21 years with cystectomy/UD performed from January 2010 to June 2015 in 3 Kaiser Permanente regions were included. All patient and surgeon data were obtained from electronic health records. A mixed effects logistic regression model was used treating surgeon as a random effect and region as a fixed effect. Results: Of 991 eligible patients, 794 (80%) received IC. One hundred sixty-nine surgeons performed the surgeries and accounted for a sizeable proportion of the variability in patient receipt of UD (intraclass correlation coefficient = 0.26). The multilevel model with only patient factors showed good fit (area under the curve = 0.93, Hosmer-Lemeshow test P = .44), and older age, female sex, estimated glomerular filtration rate <45, 4+ comorbidity index score, and stage III/IV tumors were associated with higher odds of receiving an IC vs neobladder/continent pouch. However, including surgeon factors (annual cystectomy volume, specialty training, clinical tenure) had no association (P = .29). Conclusion: In this community setting, patient factors were major predictors of UD received. Surgeons also played a substantial role, yet clinical training and experience were not major predictors. Surgeon factors such as beliefs about UD options and outcomes should be explored. (Copyright © 2018 Elsevier Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |